Science Explorer Interactive view Map
Company · New York · United States

Novartis (United States)

In research, Novartis (United States) stands highest in Medicine (#2,363 of 10,443 worldwide), Life Sciences (#1,850 of 7,800 worldwide) and Health Sciences (#3,267 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Genetics and Oncology — Genetics is 22.7× its share of world research.

novartis.usROR OpenAlex
World rank, 2022–2025
#3,834
of 28,054 · #2,627 all time
Rank in United States
#539
of 4,192
Research works
3.2k
▼ 15% vs 2013–17
Citations
121k
38.1 per fractional work
Top-10% rate
23.4%
record average 16.5%
Open access
37%
world 28%

What is Novartis (United States) known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
MedicineField #2,363 of 10,443 21.6%210 #1027
Life SciencesDomain #1,850 of 7,800 29.2%82 #1168
Health SciencesDomain #3,267 of 11,982 21.7%216 #1328

Each strip is that field’s whole ranked pool, with the notch where Novartis (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Which of those standings moved

The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.

  1. Medicine#1,027 #2,363
  2. Life Sciences#1,168 #1,850
  3. Health Sciences#1,328 #3,267
all time2022–2025, better2022–2025, worse

A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.

What does Novartis (United States) specialise in?

Where its research is concentrated relative to its size: Genetics takes 22.7× the share of its output that it takes of world research.

  1. GeneticsSubfield · 22.2 works23×
  2. OncologySubfield · 23.9 works5.9×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.10× its world share, 2 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.78× its world share, 53 worksBiochemistry, Geneti…Immunology and Microbiology: 5.02× its world share, 18 worksImmunology and Micro…Neuroscience: 0.83× its world share, 5 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 3.95× its world share, 5 worksPharmacology, Toxico…Chemical Engineering: 0.07× its world share, 0 worksChemical EngineeringChemistry: 1.40× its world share, 8 worksChemistryComputer Science: 0.53× its world share, 15 worksComputer ScienceEngineering: 0.09× its world share, 5 worksEngineeringEnvironmental Science: 0.03× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.06× its world share, 1 worksMaterials ScienceMathematics: 1.75× its world share, 7 worksMathematicsPhysics and Astronomy: 0.10× its world share, 1 worksPhysics and AstronomyDentistry: 0.01× its world share, 0 worksDentistryHealth Professions: 0.51× its world share, 5 worksHealth ProfessionsMedicine: 3.05× its world share, 210 worksMedicineNursing: 0.50× its world share, 1 worksNursingVeterinary: 2.08× its world share, 1 worksVeterinaryArts and Humanities: 0.10× its world share, 1 worksArts and HumanitiesBusiness, Management and Accounting: 0.17× its world share, 2 worksBusiness, Management…Decision Sciences: 0.43× its world share, 2 worksDecision SciencesEconomics, Econometrics and Finance: 1.50× its world share, 12 worksEconomics, Econometr…Psychology: 0.27× its world share, 3 worksPsychologySocial Sciences: 0.05× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 5.0×. Every wedge is a field page.

Who are the top researchers at Novartis (United States)?

Ranked on the composite score, Amy Chen, Peter Atadja and Randi Isaacs lead among researchers whose main affiliation is Novartis (United States).

  1. 1 Amy Chen United States · #78,029 worldwide 199 citations · 40 works
  2. 2 Peter Atadja United States · #123,523 worldwide 334 citations · 43 works
  3. 3 Randi Isaacs United States · #245,553 worldwide 303 citations · 16 works
  4. 4 Thomas J. Blacklock United States · #435,439 worldwide 123 citations · 30 works
  5. 5 Thomas M. Smith United States · #448,383 worldwide 93 citations · 25 works
  6. 6 John A. Tallarico United States · #484,649 worldwide 166 citations · 15 works
  7. 7 Paul Gallo United States · #505,585 worldwide 113 citations · 15 works
  8. 8 Kristijan H. Kahler United States · #510,667 worldwide 59 citations · 16 works
  9. 9 Maurizio Voi United States · #565,019 worldwide 76 citations · 15 works
  10. 10 Wenkui Li United States · #654,564 worldwide 44 citations · 17 works
All ranked researchers at Novartis (United States)

Which keywords describe research at Novartis (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Clinical Trials, Prognostic Factors, Epidemiology, Inflammation, Chemotherapy, Immunotherapy, Mutation and Clinical Management.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology28▲ 1.97×76 topics
  2. Inflammation20▲ 2.7×55 topics
  3. Clinical Trials18▲ 7.3×13 topics
  4. Prognostic Factors14▲ 9.2×10 topics
  5. Quality of Life13▲ 2.5×18 topics
  6. Chemotherapy13▲ 5.2×20 topics
  7. Diagnosis13▲ 3.9×21 topics
  8. Immunotherapy12▲ 4.8×14 topics
  9. Treatment12▲ 2.8×29 topics
  10. Biomarkers10▲ 4.2×15 topics
  11. Mutation10▲ 15×4 topics
  12. Clinical Management10▲ 16×6 topics
  13. Antisense Oligonucleotides10▲ 63×2 topics
  14. Neuromuscular Junction9▲ 63×2 topics
  15. SMN19▲ 119×1 topic
  16. Spinal Muscular Atrophy9▲ 119×1 topic
  17. Heart Failure9▲ 5.9×13 topics
  18. Genetic Variants9▲ 14×6 topics
  19. Lymphoma9▲ 16×3 topics
  20. Cancer Immunotherapy8▲ 15×3 topics
  21. Cardiovascular Disease Prevention8▲ 26×2 topics
  22. Rituximab8▲ 15×4 topics
  23. Breast Cancer8▲ 9.0×8 topics
  24. Statins8▲ 29×2 topics
  25. Pharmacokinetics8▲ 7.9×4 topics
  26. Targeted Therapy8▲ 9.4×5 topics
  27. Innate Immunity7▲ 6.5×7 topics
  28. Tumor Regression7▲ 18×2 topics
  29. BCR-ABL7▲ 73×1 topic
  30. Imatinib7▲ 73×1 topic
  31. C-Reactive Protein7▲ 26×2 topics
  32. CAR T Cells7▲ 26×1 topic
  33. Chimeric Antigen Receptor7▲ 26×1 topic
  34. Cholesterol-lowering7▲ 42×1 topic
  35. LDL Cholesterol7▲ 55×1 topic
  36. Autoantibodies6▲ 7.8×7 topics
  37. Glomerular Diseases6▲ 55×1 topic
  38. Nephrotic Syndrome6▲ 55×1 topic
  39. Therapeutic Targets6▲ 12×5 topics
  40. Monoclonal Antibodies6▲ 19×3 topics

Which research topics does Novartis (United States) publish most on?

By volume in 2022–2025: Neurogenetic and Muscular Disorders Research, Chronic Myeloid Leukemia Treatments, Lipoproteins and Cardiovascular Health and CAR-T cell therapy research.

Neurogenetic and Muscula…9Neurogenetic and Muscular Disorders Research: 9 fractional worksChronic Myeloid Leukemia…7Chronic Myeloid Leukemia Treatments: 7 fractional worksLipoproteins and Cardiovascular Health: 7 fractional worksCAR-T cell therapy resea…7CAR-T cell therapy research: 7 fractional worksRenal Diseases and Glome…6Renal Diseases and Glomerulopathies: 6 fractional worksChronic Lymphocytic Leukemia Research: 6 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 5 fractional worksComputational Drug Disco…5Computational Drug Discovery Methods: 5 fractional worksAcute Myeloid Leukemia Research: 5 fractional worksComplement system in diseases: 4 fractional works
GeneticsHematologySurgeryOncology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Neurogenetic and Muscular Disorders Research Genetics 9 works
  2. 2 Chronic Myeloid Leukemia Treatments Hematology 7 works
  3. 3 Lipoproteins and Cardiovascular Health Surgery 7 works
  4. 4 CAR-T cell therapy research Oncology 7 works
  5. 5 Renal Diseases and Glomerulopathies Nephrology 6 works
  6. 6 Chronic Lymphocytic Leukemia Research Genetics 6 works
  7. 7 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 5 works
  8. 8 Computational Drug Discovery Methods Computational Theory and Mathematics 5 works
  9. 9 Acute Myeloid Leukemia Research Hematology 5 works
  10. 10 Complement system in diseases Immunology 4 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available37.3%not open62.7%

World: 28% of research is openly available.

with international co-authors44.8%domestic only55.2%

World: 19% is written across borders.

How has Novartis (United States)'s research output changed?

Output in 2018–2022 was 15% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in New York

All research institutions in New York

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.